Repligen Corporation's Upcoming Presentation at Healthcare Conference
Repligen Corporation (NASDAQ:RGEN), a prominent name in life sciences specializing in bioprocessing technology, has announced a significant event for its stakeholders. The company will be presenting at the Wells Fargo Healthcare Conference, which is set to take place from September 4-6 in Boston. Olivier Loeillot, the President and Chief Executive Officer, will participate in an analyst-led discussion on September 6, at 8:45 a.m. ET.
Event Details and Access
For those who wish to follow along, a live webcast of the presentation will be available. Attendees can access this through Repligen’s Investor Relations website. Furthermore, the webcast will be offered for replay for a limited time following the conference, ensuring that anyone interested can catch up on this important presentation.
About Repligen Corporation
Repligen Corporation is a key global player in the life sciences sector, committed to advancing bioprocessing technologies. These technologies play a crucial role in improving the efficiency and effectiveness of biological drug manufacturing processes. The company lives by its mission of “inspiring advances in bioprocessing”, serving a wide range of clients, including biopharmaceutical developers and contract development and manufacturing organizations (CDMOs) around the world.
Key Areas of Focus
Repligen's core areas of expertise include Filtration and Fluid Management, Chromatography, Process Analytics, and Proteins. This targeted approach streamlines production processes, resulting in faster and more efficient drug development cycles. As a leader in innovation, Repligen consistently strives to enhance its offerings to meet the changing needs of the biopharmaceutical industry.
Global Operations
The corporate headquarters of Repligen are strategically situated in Waltham, Massachusetts. The company boasts extensive manufacturing capabilities primarily in the U.S., along with key facilities located in several countries, including Estonia, France, Germany, Ireland, the Netherlands, and Sweden. This international presence allows Repligen to effectively serve its global clientele and maintain a strong supply chain for its innovative products.
Company Contact Information
If you have any questions or need more detailed information about Repligen Corporation, please contact Sondra S. Newman, the Global Head of Investor Relations. She can be reached at (781) 419-1881 or via email at investors@repligen.com.
Frequently Asked Questions
What is the purpose of Repligen's presentation at the conference?
The presentation is designed to highlight innovations and advancements in bioprocessing technologies, demonstrating the company's leadership in this vital sector.
Who will represent Repligen at the Wells Fargo Healthcare Conference?
Olivier Loeillot, the President and Chief Executive Officer of Repligen Corporation, will be leading the presentation for the company.
How can attendees access the conference presentation?
A live webcast of the presentation will be available on Repligen’s Investor Relations website, with replay options accessible for a limited time after the event.
What are the main areas of focus for Repligen Corporation?
Repligen specializes in Filtration and Fluid Management, Chromatography, Process Analytics, and Proteins, all aimed at enhancing bioprocessing efficiencies for drug manufacturers.
Where is Repligen Corporation headquartered?
Repligen Corporation is headquartered in Waltham, Massachusetts, with manufacturing facilities located across the U.S. and in several other countries.
